Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hopkins scientists uncover role of Fanconi’s Anemia genes in pancreatic cancer

15.05.2003


Scientists at the Johns Hopkins Kimmel Cancer Center have identified three genes, long linked to a rare inherited disease known as Fanconi’s Anemia (FA), that now appear to play a role in many cases of pancreatic cancer.



All of the genes identified, when functioning normally, are part of the DNA repair process. The work is reported in the May 15, 2003 issue of Cancer Research.

"What we think we have is a new genetic cause of some cases, approximately 10 percent or more, of pancreatic cancers, one of the most lethal forms of cancer," according to Scott Kern, M.D., professor of oncology and pathology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and director of the study. The good news is that these genes offer new targets for improved treatment, he says.


The genes have all been associated with Fanconi’s Anemia. Those affected are born with only a single normal copy of one or more of the genes. Though they do not develop FA, these people often develop pancreatic cancer, usually in their 40s and 50s, about a decade earlier than average age of onset, according to Kern.

"The up side is that while these gene mutations cause a horrific disease, they may actually be the Achilles heel of the tumor and make these particular cancers more responsive to treatment," says Kern.

The culprit genes, including BRCA2, linked by other earlier studies to breast cancer, as well as two other genes FANCC and FANCG, appear to make pancreatic cancer cells highly susceptible to treatment with two FDA-approved cancer drugs mitomycin C and cisplatin. Human clinical trials are now being planned.

Normally, the genes are responsible for keeping DNA in good repair. As DNA is copied for cell replication, these genes compare the copies of DNA and fix any breaks. Mitomycin C and cisplatin work by causing the exact breaks these genes are supposed to repair. In the subset of patients whose pancreatic cancer is caused by mutations of these repair genes, the cancer cells are missing this repair mechanism making them unable to fix the breaks caused by the drugs, so the cancer cells should die, Kern says.

Both drugs are currently used in pancreatic cancer therapy, and though some remissions have been reported, the drugs have been largely ineffective. Kern suspects it’s a matter of a patient selection and dose.

Kern says preliminary laboratory and animal studies suggest low doses over a prolonged period of time may have the most benefit, and probably only in patients with FA gene mutations. He is now working with other investigators to develop clinical trials to study the drugs in patients with early onset disease, which may be caused by FA gene mutants.

In the study, the scientists examined a panel of human pancreatic cancers. They found mutations of FA-related genes in three of nine of tumor samples from patients aged 50 or younger. The researchers believe these mutations are common among the general population, estimating that about 1 in every 300 people have inherited a mutated copy of at least one FA gene.

"Our findings also tell us that cancers that appear to occur randomly in the population may not always really be so random," Kern says. "It is likely that the origin of many cancers could be traced back to similar inherited genetic mutations," says Kern.

People born with just one normal copy of the FA genes have an unfortunate head start on the cancer process, Kern says. If that one good copy is lost from dietary and/or environmental exposures, the cellular mistakes go unchecked, accelerating the initiation of cancer. He suspects these mutations could be responsible for a subset of other cancers as well, including certain breast, ovarian, and prostate cancers.

Fanconi’s Anemia occurs in less than 1 in 100,000 people, caused by the hereditary loss of both copies of an FA gene. People with FA are born with skeletal abnormalities and often develop cancers early in life. Until now, experts did not believe the loss of only one FA gene also was disease-related. "Something we thought was not causing disease, we now suspect causes one of the worst forms of cancer," says Kern.

Pancreatic cancer has one of the lowest survival rates among all cancers. Each year, approximately 30,300 Americans are diagnosed with the disease, and nearly 30,000 die. Often unresponsive to conventional therapies, pancreatic cancer is the fourth leading cause of cancer death.

In addition to Kern, other participants in this study were Michiel S. van der Heijden, Charles J. Yeo, and Ralph H. Hruban.


This research was funded by a National Cancer Institute gastro-intestinal SPORE (Specialized Projects of Research Excellence) grant.

Valerie Matthews Mehl | EurekAlert!
Further information:
http://www.hopkinsmedicine.org
http://www.hopkinskimmelcancercenter.org

More articles from Health and Medicine:

nachricht Scientists learn more about how gene linked to autism affects brain
19.06.2018 | Cincinnati Children's Hospital Medical Center

nachricht Overdosing on Calcium
19.06.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Creating a new composite fuel for new-generation fast reactors

20.06.2018 | Materials Sciences

Game-changing finding pushes 3D-printing to the molecular limit

20.06.2018 | Materials Sciences

Could this material enable autonomous vehicles to come to market sooner?

20.06.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>